Satsuma Pharmaceuticals (STSA) Short Interest Ratio & Short Volume

Short interest is the volume of Satsuma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 130,100 shares of STSA short. 0.46% of Satsuma Pharmaceuticals' shares are currently sold short. Learn More on Satsuma Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.46% of Satsuma Pharmaceuticals' floating shares are currently sold short.

Satsuma Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 130,100 shares, a decline of 58.0% from the previous total of 310,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Satsuma Pharmaceuticals currently has issued a total of 33,150,000 shares. Some of Satsuma Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Satsuma Pharmaceuticals currently has a public float of 28,020,000 shares.

0.46% of Satsuma Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "regional banks" compare to Satsuma Pharmaceuticals: The PNC Financial Services Group, Inc. (1.26%), Truist Financial Co. (2.14%), M&T Bank Co. (1.57%), First Citizens BancShares, Inc. (3.34%), Fifth Third Bancorp (2.65%), Huntington Bancshares Incorporated (3.73%), Regions Financial Co. (5.02%), KeyCorp (2.23%), East West Bancorp, Inc. (3.56%), First Horizon Co. (2.29%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

Short selling STSA is an investing strategy that aims to generate trading profit from Satsuma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Satsuma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of STSA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STSA, twice per month. The most recent reporting period available is May, 15 2023.